Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry
Open Access
- 25 March 1999
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 60 (4) , 289-299
- https://doi.org/10.1002/(sici)1096-8652(199904)60:4<289::aid-ajh7>3.0.co;2-w
Abstract
To investigate the applicability of noninvasive Superconducting Quantum Interference Device (SQUID) biomagnetic liver susceptometry and its limitations in thalassemic children, 23 patients with β‐thalassemia major and other iron loading anemias (age: 4–16 years) and 16 age‐related normal children were studied. Liver iron concentrations ranged from 600 to 11,000 μg/gliver for thalassemic patients and from 60 to 340 μg/gliver for normal patients. Measuring the respective organ volumes by sonography, liver and spleen iron stores, accounting for 80% of total body iron stores, were estimated. Nonliver contributions from the lung or intestine to the measured SQUID signals in the small‐sized patients were not observed. Moreover, livers in thalassemia were found to be enlarged by 18% per 1,000 μg/g (r = 0.75, P < 10−3). Serum ferritin values correlate significantly with iron stores (r = 0.64, P < 10−3), but predict iron stores only within large error intervals of 4,000 μg/gliver. Analyzing the experimental data from biomagnetometry and from related transfusion and chelation treatment data within the framework of a two‐compartment model, we were able to derive additional information on total body iron elimination and chelation therapy efficacy. The exponential decline of iron stores allows forecast of steady‐state conditions of the final iron load for a particular transfusion and chelation therapy regimen. Am. J. Hematol. 60:289–299, 1999.Keywords
This publication has 32 references indexed in Scilit:
- Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress.Proceedings of the National Academy of Sciences, 1996
- Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiproneBritish Journal of Haematology, 1995
- Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia majorAmerican Journal of Hematology, 1993
- Noninvasive Methods for the Early Detection of Hereditary HemochromatosisAnnals of the New York Academy of Sciences, 1988
- Liver volume measurement by ultrasonography in normal subjects and alcoholic patientsJournal of Hepatology, 1986
- Magnetic-Susceptibility Measurement of Human Iron StoresNew England Journal of Medicine, 1982
- Binding of Serum Ferritin to Concanavalin A: Patients with Hornozygous β Thalassaemia and Transfusional Iron OverloadBritish Journal of Haematology, 1980
- Serum ferritin, liver iron stores, and liver histology in children with thalassaemia.Archives of Disease in Childhood, 1980
- LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIAAnnals of the New York Academy of Sciences, 1974
- HemosiderinActa Haematologica, 1960